Caribou Biosciences, Inc. Share Price
CRBUCaribou Biosciences, Inc. Stock Performance
Open $2.13 | Prev. Close $2.12 | Circuit Range N/A |
Day Range $2.00 - $2.32 | Year Range $0.78 - $3.54 | Volume 1,91,336 |
Average Traded $2.23 |
Caribou Biosciences, Inc. Share Price Chart
About Caribou Biosciences, Inc.
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally. The company's lead product candidate include CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma, refractory systemic lupus erythematosus, lupus nephritis, and extrarenal lupus. It also develops CB-011, an anti-BCMA allogeneic CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Caribou Biosciences, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
13-May-26 | $2.00 | $2.11 | +3.69% |
12-May-26 | $2.02 | $2.04 | +0.49% |
11-May-26 | $1.96 | $2.02 | +4.65% |
08-May-26 | $1.91 | $1.94 | +3.75% |
07-May-26 | $1.92 | $1.86 | -4.11% |
06-May-26 | $1.97 | $1.95 | +1.30% |
05-May-26 | $1.98 | $1.92 | +0.52% |
FAQs on Caribou Biosciences, Inc. Share Price
Can I buy Caribou Biosciences, Inc. shares in India?
What is the share price of Caribou Biosciences, Inc.?
What is the 5 year returns of Caribou Biosciences, Inc.?
What are the high & low stock price of Caribou Biosciences, Inc. today?
What is the 52-week high and low of Caribou Biosciences, Inc. stock?